Elanco Animal Health, Inc. (ELAN)
24.68
+0.76
(+3.20%)
USD |
NYSE |
Sep 02, 16:00
24.68
0.00 (0.00%)
After-Hours: 20:00
Elanco Animal Health Research and Development Expense (Annual) : 368.00M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 368.00M |
| December 31, 2024 | 344.00M |
| December 31, 2023 | 327.00M |
| December 31, 2022 | 321.00M |
| December 31, 2021 | 369.00M |
| December 31, 2020 | 327.00M |
| Date | Value |
|---|---|
| December 31, 2019 | 270.10M |
| December 31, 2018 | 246.60M |
| December 31, 2017 | 251.70M |
| December 31, 2016 | 265.80M |
| December 31, 2015 | 291.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Zoetis, Inc. | 698.00M |
| Eli Lilly & Co. | 13.34B |
| ANI Pharmaceuticals, Inc. | 51.66M |
| EyePoint, Inc. | 221.04M |
| Amylyx Pharmaceuticals, Inc. | 89.88M |